两种离心流左心室辅助装置作为心脏移植桥接的比较
本研究基于UNOS胸科移植数据库,比较HeartWare HVAD与HeartMate III作为心脏移植桥接的患者结局。共纳入569例患者,HM3组226例,HVAD组343例。
要点
- HVAD与HM3作为心脏移植桥接,1年死亡率无统计学差异。
- 移植后1年生存率两组亦无显著差异。
- 需更多真实世界经验或随机试验判断孰优。
核心结论
- 在相对匹配的离心流LVAD桥接患者中,等待期及移植后6个月和1年死亡率无统计学差异。
临床怎么用
- 在选择离心流LVAD作为心脏移植桥接时,HVAD与HM3的短期生存结局相似,可根据患者特征个体化选择。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Use of continuous-flow left ventricular assist devices (LVAD) has increased over the years as a bridge to transplant. The HeartWare HVAD (Medtronic, Minneapolis, MN) and HeartMate III (HM3, Abbott, Abbott Park, IL) are currently approved centrifugal-flow devices used for bridge to transplant. We sought to evaluate outcomes of the patients listed and who received a transplant after receiving these 2 devices. METHODS: The United Network of Organ Sharing thoracic transplant database was queried after August 23, 2017, until December 2018 to identify patients aged older than 18 years listed for heart transplant and supported by the HVAD or HM3. Patient characteristics were evaluated at the time of listing and transplant. The primary study end point was 1-year mortality after LVAD implantation. Nonparametric tests were used to evaluate the device groups. RESULTS: Of 569 patients listed for heart transplant during the study period, 226 had HM3 and 343 had HVAD. The HM3 group had more men (82% vs 74%, P = .02), patients with diabetes (38% vs 29%, P = .02), and the body mass index was higher (28 vs 27 kg/m2, P = .04) at listing. Between the HM3 and HVAD groups, the 1-year mortality was 20% vs 17%, respectively (log-rank P = .28; Figure 1), and the posttransplant survival at 1 year was 97% and 94%, respectively (P = .1). CONCLUSIONS: In a relatively well-matched group of patients listed for heart transplant with a centrifugal-flow LVAD, the 6-month and 1-year mortality on the waiting list as well as after transplant were not statistically different. Additional real-world experience or a randomized trial would be needed to determine whether one LVAD is superior.
引用
- Alwair H, Whitehouse K, Slaughter MS, et al. A Tale of Two Centrifugal-Flow Ventricular Assist Devices As Bridge to Heart Transplant. Ann Thorac Surg. 2021. PMID: 33857496. doi:10.1016/j.athoracsur.2021.03.093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。